Citations 2
Efficacy, Safety, and Tolerability of Ubrogepant for the Acute Treatment of Migraine: Results From a Single-Attack Phase 3 Study, ACHIEVE II (S38.008)
Trugman, Joel M. , Lu, Kaifeng , Lakkis, Hassan, Finnegan, Michelle , Szegedi, Armin, Dodick, David W. , Ailani, Jessica , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available
Orally Administered Atogepant Was Efficacious, Safe, and Tolerable for the Prevention of Migraine: Results From a Phase 2b/3 Study (S17.001)
Trugman, Joel M. , Finnegan, Michelle , Lakkis, Hassan, Lu, Kaifeng , Szegedi, Armin, Goadsby, Peter J. , Dodick, David W.
Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available